Regen BioPharma Inc Share Price OTC Bulletin Board
Equities
US75886M1027
Biotechnology & Medical Research
Sales 2022 | 236K 19.65M | Sales 2023 | 237K 19.74M | Capitalization | 6.33M 528M |
---|---|---|---|---|---|
Net income 2022 | 2M 167M | Net income 2023 | 1M 83.43M | EV / Sales 2022 | 144 x |
Net Debt 2022 | 1.22M 102M | Net Debt 2023 | 635K 52.99M | EV / Sales 2023 | 29.4 x |
P/E ratio 2022 |
13.7
x | P/E ratio 2023 |
6.24
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.99% |
Managers | Title | Age | Since |
---|---|---|---|
David Koos
CEO | Chief Executive Officer | 64 | 24/12/24 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Koos
CEO | Chief Executive Officer | 64 | 24/12/24 |
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |